Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.

Drugs
George DimopoulosMatthew E Falagas

Abstract

The evidence for traditionally recommended 7- to 14-day duration of antibacterial therapy for community-acquired pneumonia (CAP) is not well established. We endeavoured to assess the effectiveness and safety of shorter than traditionally recommended antibacterial therapy for CAP. We performed a meta-analysis of randomized controlled trials (RCTs) comparing short- (< or = 7 days) versus long- (> or = 2 days difference) course therapy for CAP with the same antibacterial regimens, in the same daily dosages. Five RCTs involving adults (including outpatients and inpatients who did not require intensive care) and two RCTs involving children (aged 2-59 months, residing in developing countries) were included. All RCTs were double-blind and assessed patients with CAP of mild to moderate severity. No differences were found between short- (adults 3-7 days; children 3 days) and long- (adults 7-10 days; children 5 days) course regimens (adults - amoxicillin, cefuroxime, ceftriaxone, telithromycin and gemifloxacin; children - amoxicillin) regarding clinical success at end-of-therapy (six RCTs; 5107 patients [1095 adults, 4012 children]; fixed-effect model [FEM]; odds ratio [OR] = 0.89; 95% CI 0.74, 1.07), clinical success at late follow-up, ...Continue Reading

Associated Clinical Trials

References

Jun 1, 1979·Annals of Tropical Medicine and Parasitology·C Awunor-Renner
Sep 12, 1991·The American Journal of Medicine·J J Schentag, C H Ballow
Jul 1, 1991·The American Journal of Medicine·S L GreenspanH K Genant
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Mar 1, 1986·Pediatric Infectious Disease·F Shann
May 1, 1993·American Journal of Epidemiology·C JokinenS Soimakallio
Jan 1, 1993·The American Review of Respiratory Disease·P MontraversC Gibert
Jan 1, 1996·International Journal of Technology Assessment in Health Care·D MoherP Tugwell
May 1, 1996·The Journal of International Medical Research·A Branthwaite, J C Pechère
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jul 1, 1997·The European Respiratory Journal·J F Guest, A Morris
Dec 11, 1997·Journal of Clinical Epidemiology·H ReyesG Gutiérrez
Feb 12, 1998·JAMA : the Journal of the American Medical Association·D GuillemotE Eschwége
May 26, 1998·JAMA : the Journal of the American Medical Association·E A HalmD E Singer
Jun 12, 1998·Tropical Medicine & International Health : TM & IH·M W WeberB M Greenwood
Jun 12, 1998·JAMA : the Journal of the American Medical Association·A L KozyrskyjM E Moffatt
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian
Feb 2, 1999·Respiratory Medicine·J P MetlayD E Singer
Dec 23, 1999·The Pediatric Infectious Disease Journal·J E HoppeH K Selbmann
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
Jul 4, 2001·JAMA : the Journal of the American Medical Association·S J SchragR E Besser
Feb 8, 2002·The New England Journal of Medicine·Kenneth McIntosh
Sep 24, 2002·Lancet·UNKNOWN Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lala M DunbarJames B Kahn
Nov 20, 2003·JAMA : the Journal of the American Medical Association·Jean ChastreUNKNOWN PneumA Trial Group
May 26, 2004·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Oct 13, 2005·The Pediatric Infectious Disease Journal·Janet R Casey, Michael E Pichichero
Jan 16, 2007·BMJ : British Medical Journal·John Fletcher
Sep 4, 2007·The American Journal of Medicine·Jonathan Z LiStephen Bent

❮ Previous
Next ❯

Citations

Mar 15, 2011·Current Infectious Disease Reports·Dominik Mertz, Jennie Johnstone
Feb 28, 2013·Current Infectious Disease Reports·Nikole M Scalera, Thomas M File
Apr 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yoshiro Hayashi, David L Paterson
Feb 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pranita D Tamma, Sara E Cosgrove
Sep 29, 2011·The Journal of Antimicrobial Chemotherapy·Nick DanemanChaim M Bell
Jul 27, 2012·The Journal of Antimicrobial Chemotherapy·Silvano EspositoSebastiano Leone
Mar 12, 2009·Current Opinion in Pulmonary Medicine·Mateo Cabre
Apr 24, 2009·Current Opinion in Pulmonary Medicine·Sergio CarbonaraGioacchino Angarano
Nov 17, 2011·Critical Care : the Official Journal of the Critical Care Forum·Thomas C HaveyNick Daneman
Aug 12, 2009·Critical Care : the Official Journal of the Critical Care Forum·Stephan HarbarthBeat Müller
Sep 29, 2012·Lung India : Official Organ of Indian Chest Society·Dheeraj GuptaUNKNOWN Pneumonia Guidelines Working Group
Jun 3, 2014·Deutsches Ärzteblatt International·Felix HolzingerChristoph Heintze
Mar 1, 2014·TheScientificWorldJournal·Marilia Rita PinzoneGiuseppe Nunnari
Oct 7, 2009·Expert Review of Anti-infective Therapy·Matthew E Falagas, Eugenios I Metaxas
Oct 14, 2008·Expert Review of Anti-infective Therapy·Matthew E FalagasArgyris Michalopoulos
May 2, 2009·Expert Opinion on Pharmacotherapy·Ilias I SiemposMatthew E Falagas
Jan 23, 2013·Revista española de geriatría y gerontología·Olga H TorresDomingo Ruiz
May 15, 2013·Revista Clínica Espanõla·E BouzaP Muñoz
Feb 6, 2016·Current Opinion in Infectious Diseases·George Dimopoulos, Dimitrios K Matthaiou
Feb 26, 2013·Médecine et maladies infectieuses·E MontassierE Batard
Feb 13, 2013·Infectious Disease Clinics of North America·Veronique NussenblattSara Cosgrove
Mar 11, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Amanda KovacichAaron M Milstone
Feb 1, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O J DyarC Pulcini
Apr 28, 2009·Infectious Disease Clinics of North America·Petros I RafailidisMatthew E Falagas
Apr 28, 2009·Infectious Disease Clinics of North America·Ilias I SiemposMatthew E Falagas
Jan 1, 2012·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Thomas M File
Aug 19, 2015·Lancet·Elena PrinaAntoni Torres
Apr 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tamar F BarlamKavita K Trivedi
Feb 19, 2015·Current Opinion in Infectious Diseases·Stefano AlibertiUNKNOWN DURATION Study Group
Sep 17, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G ChoudhuryA T Hill
May 29, 2016·Journal of the American Medical Directors Association·Joseph M Mylotte
Jul 28, 2016·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Courtney BeamWendy Stoelting-Gettelfinger
Aug 17, 2016·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Karl J Madaras-KellyUNKNOWN Pneumonia Duration of Therapy Medication Utilization Evaluation Group
Oct 18, 2016·Open Forum Infectious Diseases·Michelle K HaasTimothy C Jenkins
Dec 23, 2016·Expert Review of Anti-infective Therapy·Diego ViasusJordi Carratalà
Jan 19, 2018·The Journal of Antimicrobial Chemotherapy·Gabriel MachedaUNKNOWN ESGAP and SPILF
Jan 25, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Darunee ChotiprasitakulPranita D Tamma
Jul 11, 2018·Antimicrobial Agents and Chemotherapy·Giannoula S Tansarli, Eleftherios Mylonakis
Sep 7, 2018·The Cochrane Database of Systematic Reviews·Jesús López-AlcaldeManuel Gómez-García
Jan 21, 2010·Expert Opinion on Pharmacotherapy·Stavros Anevlavis, Demosthenes Bouros

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.